Principal

Rob Woodman joined Sofinnova in January 2007. Prior to Sofinnova, from 2005 – 2006, Rob worked in the Business Management team at Cancer Research Technology Ltd, an oncology focused technology transfer and development company in the UK, and in 2004 was a Business Analyst in the Management Consultancy Group of pharmaceutical information source IMS Health, also in the UK. Rob holds a PhD in Molecular and Cellular Biology / Oncology from the University of Cambridge and an MSc in Biochemistry from the University of Oxford.  Inventions made during the course of Rob’s PhD were patented; this IP is now part of the foundations of a biotech company.  His research was published in peer reviewed journals.